# FDA 483 - O'Barr, Thomas   MD - November 30, 2017

Source: https://www.globalkeysolutions.net/records/483/obarr-thomas-md/69cf4256-f165-4a9d-a567-1fab68c95e70

> FDA 483 for O'Barr, Thomas   MD on November 30, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: O'Barr, Thomas   MD
- Inspection Date: 2017-11-30
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of O'Barr, Thomas MD, a clinical investigator in Marietta, GA, revealed significant deficiencies in the conduct of nonclinical laboratory studies and record retention. The firm failed to adhere to study protocols regarding serious adverse event reporting, subject testing, and medication documentation. Additionally, required original records, such as ECG and lab reports, were not consistently retained.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sereen-g-morgan-murray/1900ad73-5999-471e-8f74-63627bd1aa2a)

Company: https://www.globalkeysolutions.net/companies/obarr-thomas-md/69a4b372-a12f-4261-82c4-385deb122204

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7